Medline - Class A (MDLN) closed at $34.09 on October 23, 2026, down 2.3% from the previous close, on volume of 6,884,752 shares (30-day average 8,510,815).
Data as of October 23, 2026.
23-Oct-2026
Globe Newswire (Fri, 23-Oct 6:33 AM ET)
Medline Exits Market for Front Line Care Beds
TipRanks (Wed, 21-Oct 5:45 PM ET)
Globe Newswire (Wed, 21-Oct 5:46 AM ET)
Globe Newswire (Mon, 19-Oct 6:07 AM ET)
Globe Newswire (Fri, 16-Oct 6:18 AM ET)
PRNewswire (Thu, 15-Oct 2:19 PM ET)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN
PRNewswire (Thu, 15-Oct 10:04 AM ET)
Globe Newswire (Wed, 14-Oct 6:46 AM ET)
Newsfile (Tue, 13-Oct 6:22 PM ET)
PRNewswire (Tue, 13-Oct 6:08 AM ET)
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
Medline - Class A trades on the NASDAQ stock market under the symbol MDLN.
As of October 23, 2026, MDLN stock price declined to $34.09 with 6,884,752 million shares trading.
MDLN has a beta of 0.91, meaning it tends to be less sensitive to market movements. MDLN has a correlation of 0.06 to the broad based SPY ETF.
MDLN has a market cap of $29.91 billion. This is considered a Large Cap stock.
Last quarter Medline - Class A reported $8 billion in Revenue and $.50 earnings per share. This beat revenue expectation by $172 million and exceeded earnings estimates by $.18.
The top ETF exchange traded funds that MDLN belongs to (by Net Assets): VTI, VO, VXF, VTV, VOE.
MDLN support price is $34.21 and resistance is $35.55 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MDLN shares will trade within this expected range on the day.
